Clinical Data

Close up shot of the target from a dart game
Biotech

Taiho and Cullinan secure lung cancer victory to challenge J&J

Taiho and Cullinan racked up a second phase 3 victory for their EGFR inhibitor, teeing up the partners to challenge J&J in the lung cancer niche.
Nick Paul Taylor Aug 13, 2026 6:00am
Helix

AI clinical trial agent delivers up to 82 times ROI in oncology

Aug 12, 2026 3:16pm
Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3

Jul 28, 2026 9:08am
Goal disorientation and lack of vision

Celldex ends skin disease program after failing phase 2 test

Jul 22, 2026 6:00am
GSK

GSK axes key cough drug candidate after phase 3 data disappoint

Jul 17, 2026 5:46am
Completing steps towards success checkmark on cubes symbolizing progress

Racing Takeda, InnoCare reports TYK2 inhibitor win in vitiligo

Jul 16, 2026 9:36am